In this study, we generated three SAGE libraries from melanoma tissues. Using bioinformatics tools usually applied to microarray data, we identified several genes, including novel transcripts, which are preferentially expressed in melanoma. SAGE results converged with previous microarray analysis on the importance of intracellular calcium and G-protein signaling, and the Wnt/Frizzled family. We also examined the expression of CD74, which was specifically, albeit not abundantly, expressed in the melanoma libraries using a melanoma progression tissue microarray, and demonstrate that this protein is expressed by melanoma cells but not by benign melanocytes. Many genes involved in intracellular calcium and G-protein signaling were highly expressed in melanoma, results we had observed earlier from microarray studies (Bittner et al., 2000) . One of the genes most highly expressed in our melanoma SAGE libraries was a calciumregulated gene, calpain 3 (p94). Immunohistochemical analysis demonstrated that calpain 3 moves from the nuclei of non-neoplastic cells to the cytoplasm of malignant cells, suggesting activation of this intracellular proteinase. Our SAGE results and the clinical validation data demonstrate how SAGE profiles can highlight specific links between signaling pathways as well as associations with tumor progression. This may provide insights into new genes that may be useful for the diagnosis and therapy of melanoma.
Introduction
The development of skin cancer is an increasing public health problem in the US today. Of these cancers, melanoma is the most aggressive form, affecting over 53 600 people in the US in 2002 (Desmond and Soong, 2003) . More than 13% of melanoma patients affected eventually succumb to metastatic disease. The molecular mechanisms underlying the development and progression of this disease have not been clearly elucidated. One of the main barriers to basic research in this area is the difficulty of obtaining significant quantities of fresh primary tissue, as most often the entire specimen, especially in the case of primary radial growth phase melanomas, is paraffin embedded and used for pathologic diagnosis. Furthermore, the diagnosis of a melanoma in situ is extremely rare. As a consequence, melanoma cells in tissue culture have subsequently been the source of choice for largescale gene expression analysis and genomic studies. A variety of these genomic approaches have led to the identification of several genes of interest that may be involved in melanoma oncogenesis, such as B-Raf (Davies et al., 2002) , and melanoma progression, such as RhoC (Clark et al., 2000) and Wnt5a (Bittner et al., 2000) . These studies were based on melanoma cells, either in established or primary culture, with subsequent confirmation in human tissue biopsies (Davies et al., 2002; Weeraratna et al., 2002) . In addition, these studies have opened up new avenues of thought about how melanoma cells signal (for reviews, see Hsu et al., 2002; Chin, 2003; Polsky and CordonCardo, 2003) .
While cells in culture reveal important features of tumors, any particular cell line or small collection of cell lines is nonetheless likely to represent only a portion of the biology present in the tumor itself. To gain a more complete picture of tumor biology, it is therefore important to attempt to survey the expression patterns of tumor samples. Serial analysis of gene expression (SAGE) is a powerful technique that allows for a comprehensive profiling of gene expression within a given tissue, and gives an unbiased representation of the transcripts present therein (Velculescu et al., 1995) . Unlike microarray analysis, which depends on the prior knowledge of the transcriptome, SAGE identifies all transcripts within the cell, which allows for the identification of hithertofore unknown genes or transcripts. In addition, where microarray analysis relies on a ratio-based comparison between hybridization of two different RNAs to oligos or cDNAs, SAGE is a way by which to count absolute levels of transcripts, thus eliminating bias introduced from hybridization conditions (for reviews, see Velculescu et al., 2000; Weeraratna, 2003) . Recent advances in the SAGE technique have led to the ability to perform SAGE on RNA from minute amounts of tissue (Datson et al., 1999) . Micro-SAGE analysis is particularly useful in studies of tumors such as melanoma, where, often, very small quantities of tissue are available. We were able to obtain small quantities of three melanoma tissues, representing two vertical growth phase tumors, and one distant metastasis. From 45 mg of tissue, we constructed SAGE libraries that were on average comprised of 20 000 tags. We analysed these data using bioinformatics and data display tools that have primarily been applied to cDNA microarray expression data. We included in our analysis libraries available in the NCBI SAGE databases for several other cancers, as well as a keratinocyte library, to give us a more comprehensive overview of melanoma-specific changes in gene expression.
The second challenge in the analyses of these data is gene validation. Gene expression profiles provide correlative data, providing no direct information on causalities, pathways and truly functional data.
Also, such analyses are usually restricted to small sample sets that may not reflect the entire clinical spectrum. Therefore, in this study, we used immunohistochemistry on tissue microarrays for clinical validation of the findings. To our knowledge, this is the first attempt at generating SAGE libraries from melanoma tissues, and one of a handful of studies that attempts to apply a more sophisticated analysis to SAGE data in general. The unrestricted online availability of these data may also prove a useful resource for researchers in the melanoma field, where such resources are limited.
Results

Generation and analysis of melanoma SAGE libraries
Micro-SAGE was used to generate all three libraries, as very small amounts of tissue were available. On average, 20 000 tags were obtained per library, and the source of each tissue, the melanoma grade and stage, and the number of tags generated are summarized in Table 1 . For a more comprehensive analysis of the data, other libraries were imported from the CGAP website. These include libraries from normal tissues of interest, such as keratinocytes, to give a rough estimate of which genes might be due to contamination in the bulk dissected tissue, as well as libraries from other cancers such as breast, colon and ovarian cancers. The data for source, tissue type and tag counts for all libraries are summarized in Table 1 . All of these libraries were then used to determine which genes best distinguished the melanomas from the other cancers, and keratinocytes. This was performed by normalizing all libraries to Figure 1a . These 8146 tags were then either used without further qualification to generate a weighted gene list (Figure 1b ) to determine which genes best separated the melanomas from other libraries, or subjected to a second round of selection. It is interesting to note that the pattern of expression of the second melanoma library which came from the surface of the foot of an 80-year-old female, had a slightly different gene expression profile than the other two melanomas, as can be seen in the weighted gene list (Figure 1 ). The purpose of the second round of selection was to select for tags of high abundance in the melanomas (an average of greater than 240 tags per million (tpm) across the three samples). This resulted in the selection of 445 tags that were used to generate a weighted gene list ( Figure 1c ) using distance-based gene selection. The 75 genes with the most significant weight are shown in these two figures. Known melanoma genes such as chondroitin sulfate proteoglycan (Ross et al., 1983) , the silver homolog (Sakai et al., 1997) and melanA (MART1) (Demetrick et al., 1992) had significant weight (4 and over, with P-values of 0.0011, 0.0026 and 0.014, respectively), and provided good internal controls for the data generation and analysis. It is also extremely interesting to note the large number of tags that do not map to any known gene that exists in the melanoma libraries as compared to the other cancers included in this analysis. This may be due in part to the fact that many of the tags from other cancers have been more extensively studied, and are now identified, but it may also indicate the presence of novel genes (or transcript forms) expressed in melanoma. This will require further investigation.
In order to validate the accuracy of the SAGE libraries, we chose to stain a melanoma tissue microarray as described in the subsequent sections. This array contains 0.9 mm tissue cores from 353 samples, comprised of nevi, dysplastic nevi, primary melanomas, dermal metastases, and several distant metastases including lymph node metastases, subcutaneous metastases and other visceral metastases (e.g. lung, brain) (Pollock et al., 2003) . All staining was examined by two independent pathologists (PHD, KR), and scored as outlined in Tables 2 and 3 for each antibody. The potential confounding effects of melanin were excluded through examination of hematoxylin/eosin (H&E)-stained slides, and spots with excessive melanin expression were excluded from the analysis. Melanoma-specific antibodies (Melanoma Pan-Ab1, a cocktail of HMB45 and Mart1 antibodies; Labvision Corp., Fremont, CA, USA) were used to help distinguish melanoma cells from other cell populations. We chose genes that have not been previously associated with melanoma, that had significant weight on the weighted gene list, in order to test the validity of this approach in analysing the SAGE data.
Weighted gene analysis demonstrates that less abundant tags retain the ability to differentiate between benign and malignant melanocytic lesions
Our first pass analysis of the SAGE data (using 8146 tags) revealed that a number of the less abundant tags were strong discriminators for melanoma because they were expressed only in the melanoma libraries but not at all in any of the other libraries. One such gene, CD74, is expressed at a much lower level than most tags (80 tpm and 150 tpm in two of the three melanomas), but is not expressed at all in the majority of other cancers examined, and thus has a significant weight (6.39, P-value of 0.003). CD74 is the invariant chain of the major histocompatibility complex class II, and is often expressed in B-cell lymphomas (Marti et al., 1992) . In addition, expression of this antigen has been identified in cancers of nonimmune origin such as gastric cancer (Ishigami et al., 2001 ) and renal cancer (Young et al., 2001) . To validate expression of this gene in melanoma, we performed real-time polymerase chain reaction (PCR) analysis to measure the level of this gene in melanoma cell lines as compared to normal melanocytes. The majority of melanoma cell lines examined expressed high levels of this gene, where melanocytes in culture did not ( Figure 2 ). Expression of this protein has been demonstrated in one melanoma cell line, using radiolabeled antibody uptake (Ong et al., 1999) , but there has been no prior immunohistochemical analysis on tumor biopsies. To determine if the expression of this gene correlated to melanoma stage, and to ensure that it was not based on infiltrating immune cells into the tumor, we used an antibody to CD74 to stain the melanoma tissue microarray (Figure 3 ). H&E staining corresponding to CD74 staining is shown at both low power ( Analysis of melanoma SAGE libraries using distance-based gene selection. A standard deviation of greater than 1.5 between the melanoma SAGE libraries and the other libraries was applied to identify tags that were differentially expressed between these two groups. This list was used to generate a multidimensional scaling diagram (a) and a weighted gene list (b). In order to determine which tags were highly expressed in melanoma, and also specific, these data were further selected for genes with an average expression of greater than 240 tpm across the three libraries, and a second weighted gene list was generated (c) Visceral metastases showed a similar staining pattern to subcutaneous metastases, and an example of a negatively staining tumor is shown to demonstrate the specificity of this antibody (Figure 3 , L,R).
Genes associated with G-protein and calcium signaling constitute a significant portion of both weighted gene lists It was of interest to us, based on our previous studies which implicate the Wnt/calcium pathway in melanoma progression (Weeraratna et al., 2002) , that many genes associated with changes related to calcium flux were highly upregulated (higher than 150 tpm, with ranges from 170 to 2364 tpm) in our melanoma samples. These genes had a very significant weight in both sets of gene selection analyses. Calcium-responsive genes that were highly expressed include the calcium homeostasis endoplasmic reticulum protein, responsible for the mobilization of intracellular calcium and also for cell proliferation (O'Rourke et al., 2003) ; signal sequence receptor, gamma (translocon-associated protein gamma) (SSR3) (Rapoport, 1991) , associated with secretion from the endoplasmic reticulum; the calcium promoted ras-inactivator (CAPRI) (Lockyer et al., 2001) ; the homolog of the Drosophila gene, frequenin (Wang et al., 2001) , which has been shown to be important in neurotransmission, in response to calcium fluxes, and can also activate PI-4-kinase (Weisz et al., 2000) ; and a calcium channel, voltage-dependent, alpha 2/delta subunit (CACNA2D2). Calponin 2 was expressed in all other libraries, but not those of melanoma origin, which was of great interest to us as this gene is responsible for inhibiting actin activity in the cytoskeleton (Hodgkinson, 2000) , a key feature of motility. It has been previously demonstrated that calponin downregulation is a marker of poor prognosis in melanoma patients, because the loss of this protein contributes to the fragility of blood vessels within the tumor, facilitating the intravasation of melanoma cells (Taniguchi et al., 2001) . Another calcium-regulated protein with a very significant weight on the weighted gene list, and which is highly expressed at 150-520 tpm in the melanoma libraries, but not at all in any of the other libraries examined (giving it a weight of 5.59, P-value of 0.0014), is the protein calpain 3 (p94). Calpains, which are members of an intracellular protease superfamily (Ohno et al., 1990) , are notable in melanoma for their ability to downregulate p27 Kip1 , by degrading it (Delmas et al., 2003) , but calpain 3 has never been shown to be important in this disease. Calpain 3 is most abundant in muscle tissue (Richard et al., 1999) . To ascertain if this protein was expressed in human melanomas, we stained the melanoma tissue array with an antibody to calpain 3, and found that where almost all nevi expressed this protein, expression of the protein was completely restricted to the nucleus (Figure 4 , G,M). In primary melanomas and dermal metastases, expression could be seen both in the nuclei and the cytoplasm (Figure 4 , H, N, I, O), but in the other metastases examined, only cytoplasmic staining could be observed (Figure 4 , J, P, K, Q, L, R).
Finally, another group of calcium-related genes all mapped to 1q21, a locus of frequent chromosome rearrangement in melanomas (Smedley et al., 2000) . This locus codes for the S100 calcium binding proteins A7 (psoriasin 1), A9 (calgranulin B), A8 (calgranulin A) and A2, and S100b (neural) (Donato, 2001) , highly expressed in all three melanomas (ranging from 280 to 2360 tpm, with an average of 820 tpm). S100 genes are often thought to be keratinocyte genes specifically, but of these only A2 and A9 were also highly expressed in keratinocytes (3520 and 2580 tpm, respectively). Additionally, the melanoma sample dissected from a lymph node metastasis showed high levels of the other S100 proteins as well, arguing against possible keratinocyte contamination of the samples. S100b has been used to assist in the diagnosis of melanoma for several years; however, it is becoming evident that very specific isoforms of these proteins are expressed in different melanocytic lesions (Ribe and McNutt, 2003) , as well as other cancers (El-Rifai et al., 2002) . None of the other cancers in our test data set showed this level of expression for S100b, A7 and A8, and only one ovarian P-values were calculated using a two-tailed Fisher's exact test, where the samples with any nuclear staining at all (outcome 1) were compared to samples with purely cytoplasmic staining (outcome 2). Between nevi and primary, and nevi and all cancers, Po0.0001
tumor showed a high level of expression of S100A2. It is interesting to note that the almost identical cohort of S100 genes is also upregulated in gastric cancers (ElRifai et al., 2002) , another cancer where Wnt5a plays a significant role (Saitoh et al., 2002) . In keeping with the notion that the Wnt/calcium pathway may be important in the progression pathway of melanoma, via the binding of Wnt to its G-proteincoupled receptors (Dejmek et al., 2003) , several Gprotein signaling molecules, including regulator of G-protein signaling 12 and 14, were highly expressed in these samples. Interestingly, when comparing the genes that were highly expressed in the other cancers but not in melanoma, other signaling proteins, such as the 68 kDa beta-induced transforming growth factor, were significantly expressed, but not many were involved in G-protein signaling. In addition, another G-proteinresponsive molecule, PLC gamma, was also significantly expressed in melanoma, as were the genes inositol-1,4,5-triphosphate-3 kinase B and C, and PKC theta, consistent with increases in phospholipid turnover in the membrane and subsequent signal transduction via PKC, as we have previously demonstrated in melanoma cell lines (Weeraratna et al., 2002) . SAGE tags for Wnt5a itself have proved to be somewhat unreliable (digital northerns for this SAGE tag detect a maximum of 70 tpm in one ovarian library, and 10-40 tpm in a few other libraries, largely glioblastoma and astrocytoma), but Wnt10a is highly expressed in two out of the three melanomas, at 140 and 800 tpm. Although the comparison between VGP tumors and the visceral metastasis is limited, as there is only one metastasis library available, it nonetheless provides potentially valuable insights. A significantly expressed group of genes in the metastasis were involved with Wnt signaling, most interestingly frizzled 7, which has been shown to act via disheveled to activate the Wnt/calcium/ PKC pathway (Sheldahl et al., 2003) . Other genes involved in wnt signaling include the junction plakoglobin (Eisenberg et al., 1997) and the Drosophila homolog enhancer of zeste, a polycomb group repressor protein (Jones et al., 1998) . Discussion SAGE is a highly efficient technique for developing an understanding of the overall gene expression profile of a given cell or tumor. Analysis of these three melanoma libraries reveals some striking features. Melanomas have a large number of tags that do not match to any known UniGene sequences and may represent novel genes or transcripts. By using gene selection mechanisms such as those described here, we can determine which tags are most likely to be expressed specifically in melanomas. Using these methods, we can remove other highly expressed tags that may be derived from contaminating cell types. For example, the most highly expressed tag in There is a similar distribution of staining in subcutaneous metastases as in primary tumors, and a significant portion demonstrates light staining and several stain intensely (J,P). Some lymph node metastases stain negative, but a significant portion stain quite strongly positive (K,Q). It is important to note that infiltrating cell types express this antigen, such as dendrocytes (M, arrow) and B lymphocytes, although T lymphocytes do not show any positivity (Q, arrow). Visceral metastases have a similar distribution of staining among samples to subcutaneous metastases where some are negative (L,R) with the remaining samples divided equally between moderate and intense staining the melanoma libraries mapped to the gene HEI10 (human enhancer of invasion 10/hypothetical protein FLJ11151). However, this gene did not appear on the weighted gene list because it was also highly expressed in several other libraries. This does not imply, however, that this gene may not be relevant for melanoma, and the expression pattern of this protein in melanoma has been examined using optical imaging (Pfaff-Smith et al., 2004) . With this small sample set, it is not possible to distinguish between the vertical growth phase tumors and the distant metastasis. However, by validating the genes represented on the weighted gene list using our progression tissue microarray, we were able to identify several genes that showed distinct expression profiles in a large sample set of melanoma tissues.
It is already known that the interaction between melanoma and the immune system is significant. Many genes involved in signaling to cells of the immune system were specifically expressed in melanoma. These included the interleukin 6 receptor, interleukin 27, the antigens CD45, CD74, CD63, the squamous cell carcinoma Figure 4 Calpain 3 expression in melanoma. Calpain 3 exhibits a very diffuse cytoplasmic staining in muscle cells, where it was first identified. However, in nevi, this protein is heterogeneously expressed in the nucleus (G,M). In primary melanomas, the protein is expressed in both nuclei and the cytoplasm in 33% of lesions (H,N) and in the cytoplasm in the remaining tumors. In dermal metastases, this protein is expressed in the cytoplasm of most lesions, but also in both the cytoplasm and nuclei of a significant number (21%) of lesions (I,O). Subcutaneous metastases express this protein in the cytoplasm (J,P) but not in the nuclei. This is true for both lymph node metastases (K,Q) and other visceral metastases (L,R) antigen, proteinase 3 (serine proteinase, neutrophil, Wegener granulomatosis autoantigen), the macrophage migration inhibitory factor (glycosylation-inhibiting factor) and pre-B-cell leukemia transcription factor 20. In our analysis, the expression of the CD74 antigen was not simply an effect of infiltrating tumor cell types but was also expressed by the melanoma cells specifically. In fact, melanoma cells appear to present a consistently heterogeneous population, implying that at any stage of melanoma there are pre-existing cells that may be less susceptible to immune surveillance. It may be that the balance of these populations is being selected through the course of the disease to enrich the less-susceptible fraction. Interestingly, we also observed that B cells express high levels of this protein. It is possible that expression in neighboring B cells, or other immune cells, could elicit expression in the tumor cells, perhaps explaining the observation of a slightly higher percentage of CD74-positive cells in the lymph node metastases. Of interest, CD74 has very recently been demonstrated to have a high affinity for the macrophage inhibitory factor (MIF), suggesting that coexpression of these proteins may activate MIF signaling (Leng et al., 2003) and regulation of innate as well as adaptive immunity.
Given the ever-increasing accuracy of the SAGE and cDNA microarray methods, it is hardly surprising that even though the methods represent very different survey technologies, the SAGE results converge with microarray analysis on the importance of intracellular calcium and G-protein signaling, as well as participation of certain members of the Wnt/Frizzled family in melanoma (Bittner et al., 2000) . The tumors examined here were tumors in vertical growth phase and one visceral metastasis. Melanomas in vertical growth phase have already activated their invasion program, so it is not surprising that these tumors would also express genes necessary for G-protein-mediated calcium/PKC signaling as part of this process. It is interesting to note that many of the proteins for which we stained underwent a translocation in subcellular localization (data not shown). In the case of calpain 3, which translocates from the nucleus to cytoplasm, the hypothesis why a subcellular translocation of this protein might contribute to tumorigenesis arises from an elegant study by Delmas et al. (2003) . The authors show that p27
Kip1 is partially localized in the cytoplasm in OCM melanoma cells, but not in melanocytes, where it is restricted to the nucleus. P27
Kip1 is involved in inducing apoptosis, and is downregulated by MAP kinase, which in turn is upregulated by B-RAF (Davies et al., 2002) . This MAP kinase downregulation of p27
Kip1 is calpain dependent, and in fact Delmas et al. show that calpain itself is capable of degrading p27
Kip1 in vitro. It may be that this shift of calpain 3 from the nucleus to cytoplasm could also contribute to a loss of control of the cell cycle, which in turn would contribute to tumor progression. This is also supported by the fact that the staining of this protein is heterogeneously expressed in the nucleus of our nevi samples, perhaps suggesting that cells are expressing it during specific stages of the cell cycle. However, it has never been demonstrated that calpain 3 acts on p27 Kip1 , as do other members of this family. These observations lend further credence to the importance of calcium signaling in melanoma progression.
SAGE provides a massive amount of data. The analysis we have presented using currently available bioinformatics tools is not exhaustive, and the data from these melanoma libraries still provide significant opportunity for further investigation. For example, a large number of tags do not correspond to any known UniGene sequences. These tags can be used to guide cDNA cloning efforts to identify novel genes that may be important in melanoma biology. It is our hope that by making the data from these libraries publicly available, other researchers will be able to utilize this information, potentially identifying novel markers for diagnosis and therapy of melanoma. High-throughput functional and clinical validation methods, as illustrated by the few examples here, can then be adapted to derive mechanistic correlations and identify pathways, perhaps providing novel therapeutic opportunities as well as molecular profiles for diagnostic assessment of melanoma patients. For example, observing common elements of the G-protein-mediated calcium/PKC signaling pathways in tumors using a variety of survey methods provides a strong impetus to continue and expand studies on the interaction of the proteins that comprise this pathway, SAGE advice that we are following in our studies of melanoma.
Materials and methods
Micro-SAGE
Tissues selected were as follows: one vertical growth phase melanoma from the upper left scapula of a 46-year-old male, Clark's level 5; one vertical growth phase melanoma from the plantar surface of the left foot of an 80-year-old female, Clark's level 5; and one desmoplastic melanoma metastasis from under the left cheek of a 78-year-old male, Clark's level 5. A measure of 45 mg of these tissues identified by pathology to be largely comprised of tumor cells was lysed in 1 ml DyNAL bead lysis buffer (DynalCorp., Oslo, Norway) according to the manufacturer's protocol. Cells were then bound to oligodT(25) Dynabeads. Reverse transcription and cDNA synthesis reactions were performed on the RNA while bound to the beads, according to the protocol of Datson et al. (1999) , with slight modifications. cDNA synthesis was performed using the cDNA synthesis system from Invitrogen (Carlsbad, CA, USA). Anchoring and tagging reactions were performed while cDNA was bound to the beads, as well as linker ligation. Tags were then released from the beads by BsmF1 digestion, bluntended, ligated and PCR-amplified. Ditags were isolated from the amplified library, concatemerized and then used to transform bacteria via ligation into a pZero vector, according to the Kinzler/Vogelstein protocol (Velculescu et al., 1995) . Bacterial colonies were analysed by the PCR to determine which libraries had a sufficient number of SAGE tags per insert, and these clones were then sequenced by Agencourt Bioscience Corp (Beverly, MA, USA) via collaboration with the Cancer Genome Anatomy Project (CGAP) consortium. The data have been posted on the CGAP website as part of the SAGEgenie database (http://cgap.nci.nih.gov/SAGE) (Lash et al., 2000) .
SAGE data analysis
Tags were identified using the SAGE 3000 software, and normalized to tags per 50 000 for each library. Libraries were downloaded from the SAGE website for comparison and are described in Table 1 . All tags were imported into a FileMaker database and all tags with a standard deviation in expression value of at least 1.5 among samples were used to generate a multidimensional scaling diagram and perform gene selection among classes, based on linear discriminant analysis, as previously described (Bittner et al., 2000) . To evaluate the probability of a given tag achieving a significant weight by chance, a random permutation test using 1000 permutations was used to generate an empirical significance threshold for comparison with the calculated P-value for each gene.
Immunohistochemistry
Immunohistochemistry was performed on a melanoma tissue microarray constructed as previously described (Pollock et al., 2003) . Antibodies tested were those against Calpain 3(p94) (Affinity Bioreagents, Golden, CO, USA) and CD74 (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Antigen retrieval was performed using a xylene/ethanol series for 3 min eachxylene, xylene, xylene, 100% ethanol, 100% ethanol, 95% ethanol, 85% ethanol and 70% ethanol) -and then steamed in a sodium citrate buffer (DAKO target retrieval solution; DAKO Corp., Carpinteria, CA, USA) for 30 min. Tissues were then blocked for 30 min with a peroxidase block, and for 5 min with a biotin block. Tissues were stained with the aforementioned antibodies at a concentration of 1 : 100 for the CD74 antibody, and 1 : 50 for the Calpain antibody, overnight at 41C in a humidified chamber. Secondary staining was performed using the Labvision ABC system, according to the manufacturer's protocol (Labvision, Fremont, CA, USA), with DAB chromagen as a final step. Due to the nature of the tissue array, where each spot is only 0.9 mm, the entire specimen was considered. Staining was scored using the 1-3 þ system with the addition of scoring the percentage of melanoma cells positive. Melanoma cells were identified using the melanoma Pan Ab-1 antibody from Labvision, a cocktail of HMB45, and MART1. Tissues were stained with the readymade solution from the manufacturer, and incubated overnight at 41C in a humidified chamber. All staining was examined by two independent pathologists (PHD, KR). Melanin confounding of the results was determined using a H&E-stained slides, and spots with excessive melanin expression were excluded from the analysis.
Real-time RT-PCR
Primers were designed for use with the Perkin-Elmer 5700 system. Primers were designed to generate products of less than 200 bp for efficient analysis, and are listed as follows: CD74, forward 5 0 -AGAACCTGCAGCTGGAGAAC-3 0 ; reverse 5 0 -CCATACTTGGTGGCATTCT-3 0 . cDNA was transcribed from 1 mg of total RNA, according to the manufacturer's protocol (Applied Biosystems, Foster City, CA, USA) and 5 ng of this cDNA was used in the realtime RT-PCR reaction. Samples were normalized against the GAPDH gene, and the ratio of signal to GAPDH, and the fold increase as compared to empty vector controls was calculated using 2 ÀDDCT according to the manufacturer's protocol (PerkinElmer).
Cell culture UACC 647, M92-047 cells were grown in RPMI, with 10% FBS, 100 U/ml penicillin and 100 mg/ml streptomycin, at 37 1 C in 5% CO 2 . UACC1273-EV, UACC1273-4-3 and UACC1273-4-7 were grown in identical medium save for the addition of 500 mg/ml G418. HEMn-LP melanocytes were grown in Medium 154 with human melanocyte growth supplement (Cascade Biologics, Portland, OR, USA). RNA was extracted using Qiagen Rneasy columns (Qiagen, Valencia, CA, USA). cDNA was transcribed as above.
